Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
The 95%CI of RORs exceeded 1 for all assessable subgroups of GLP-1 RAs and DPP-4 inhibitors, suggesting a potential statistical link to the risk of biliary disorders, aligning with the general signal strength for these conditions
Cellular fatty acid metabolism and cancer
Peripheral vasculopathy, including Raynauds phenomenon (reduced blood flow in the fingers and toes)
TAS, total antioxidant status
US$ 27.10
US$ 21.72
US$ 23.20
